106 Chapter 6 REFERENCE LIST 1. Kouides PA, Phatak PD, Burkart P, Braggins C, Cox C, Bernstein Z, et al. Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 2000;6(6):643-8. 2. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia. 1999;5(1):408. 3. Wiewel-Verschueren S, Meijer K. Gynaecological and obstetrical bleeding in women with factor XI deficiency - a systematic review: response to rebuttal. Haemophilia. 2016;22(5):e436-7. 4. de Wee EM, Mauser-Bunschoten EP, Van Der Bom JG, Degenaar-Dujardin ME, Eikenboom HC, Fijnvandraat K, et al. Health-related quality of life among adult patients with moderate and severe von Willebrand disease. J Thromb Haemost. 2010;8(7):14929. 5. Gimpelson RJ. Ten-year literature review of global endometrial ablation with the NovaSure(R) device. Int J Womens Health. 2014;6:269-80. 6. Bourdrez P, Bongers MY, Mol BW. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Fertil Steril. 2004;82(1):160-6, quiz 265. 7. Maresh MJ, Metcalfe MA, McPherson K, Overton C, Hall V, Hargreaves J, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG. 2002;109(3):302-12. 8. El-Nashar SA, Hopkins MR, Feitoza SS, Pruthi RK, Barnes SA, Gebhart JB, et al. Global endometrial ablation for menorrhagia in women with bleeding disorders. Obstet Gynecol. 2007;109(6):1381-7. 9. De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, et al. Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost. 2011;106(5):885-92. 10. Dicicco-Bloom B, Crabtree BF. The qualitative research interview. Med Educ. 2006;40(4):314-21. 11. Qualitative Research: Theory, Method and Practice David Silverman Qualitative Research: Theory, Method and Practice Sage 390 pound21.99 0761949348 0761949348 [Formula: see text]. Nurse Res. 2005;12(4):92-3. 12. MacDougall C, Fudge E. Planning and recruiting the sample for focus groups and in-depth interviews. Qual Health Res. 2001;11(1):117-26. 13. Cote-Arsenault D, Morrison-Beedy D. Practical advice for planning and conducting focus groups. Nurs Res. 1999;48(5):280-3. 14. Huq FY, Al-Haderi M, Kadir RA. The outcome of endometrial ablation in women with inherited bleeding disorders. Haemophilia. 2012;18(3):413-20. 15. Govorov I, Ekelund L, Chaireti R, Elfvinge P, Holmstrom M, Bremme K, et al. Heavy menstrual bleeding and health-associated quality of life in women with von Willebrand’s disease. Exp Ther Med. 2016;11(5):1923-9. 16. Srivaths LV, Zhang QC, Byams VR, Dietrich JE, James AH, Kouides PA, et al. Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding. Haemophilia. 2018;24(1):63-9. 17. Reynen E, Grabell J, Ellis AK, James P. Let’s Talk Period! Preliminary results of an online bleeding awareness knowledge translation project and bleeding assessment tool promoted on social media. Haemophilia. 2017;23(4):e282-e6.
RkJQdWJsaXNoZXIy MTk4NDMw